Intranasal boosting of BCG-primed hosts with either Tri:ChAd:TB or the monovalent counterpart markedly increased CD4+ and CD8+ T cells specific to all three antigens in the airway lumen (Fig. 2D, E). The gene discussed is CD4; the disease is tuberculosis.